<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31647549</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>142</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>3771</StartPage><EndPage>3790</EndPage><MedlinePgn>3771-3790</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awz302</ELocationID><Abstract><AbstractText>It is important to understand how the disease process affects the metabolic pathways in amyotrophic lateral sclerosis and whether these pathways can be manipulated to ameliorate disease progression. To analyse the basis of the metabolic defect in amyotrophic lateral sclerosis we used a phenotypic metabolic profiling approach. Using fibroblasts and reprogrammed induced astrocytes from C9orf72 and sporadic amyotrophic lateral sclerosis cases we measured the production rate of reduced nicotinamide adenine dinucleotides (NADH) from 91 potential energy substrates simultaneously. Our screening approach identified that C9orf72 and sporadic amyotrophic lateral sclerosis induced astrocytes have distinct metabolic profiles compared to controls and displayed a loss of metabolic flexibility that was not observed in fibroblast models. This loss of metabolic flexibility, involving defects in adenosine, fructose and glycogen metabolism, as well as disruptions in the membrane transport of mitochondrial specific energy substrates, contributed to increased starvation induced toxicity in C9orf72 induced astrocytes. A reduction in glycogen metabolism was attributed to loss of glycogen phosphorylase and phosphoglucomutase at the protein level in both C9orf72 induced astrocytes and induced neurons. In addition, we found alterations in the levels of fructose metabolism enzymes and a reduction in the methylglyoxal removal enzyme GLO1 in both C9orf72 and sporadic models of disease. Our data show that metabolic flexibility is important in the CNS in times of bioenergetic stress.</AbstractText><CopyrightInformation>&#xa9; The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Scott P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woof</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francis</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Living Systems Institute, University of Exeter, Stocker Road, Exeter, EX4 4QD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gatto</LastName><ForeName>Noemi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Allan C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myszczynska</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hemingway</LastName><ForeName>Jordan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coldicott</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willcock</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Job</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Rachel M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boschian</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayatti</LastName><ForeName>Nadhim</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heath</LastName><ForeName>Paul R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bandmann</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mortiboys</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferraiuolo</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Pamela J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ALLEN/OCT15/956-799</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>K-1506</GrantID><Acronym>PUK_</Acronym><Agency>Parkinson's UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G-1202</GrantID><Acronym>PUK_</Acronym><Agency>Parkinson's UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>HAUTBERGUE/APR16/846-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>F-1301</GrantID><Acronym>PUK_</Acronym><Agency>Parkinson's UK</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.1.-</RegistryNumber><NameOfSubstance UI="D024981">Glycogen Phosphorylase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024981" MajorTopicYN="N">Glycogen Phosphorylase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">
          C9orf72
        </Keyword><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword><Keyword MajorTopicYN="N">methylglyoxal</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31647549</ArticleId><ArticleId IdType="pmc">PMC6906594</ArticleId><ArticleId IdType="doi">10.1093/brain/awz302</ArticleId><ArticleId IdType="pii">5606749</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Allaman I, Belanger M, Magistretti PJ. Methylglyoxal, the dark side of glycolysis. Front Neurosci 2015; 9: 23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4321437</ArticleId><ArticleId IdType="pubmed">25709564</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Duffy LM, Shaw PJ, Grierson AJ. Altered age-related changes in bioenergetic properties and mitochondrial morphology in fibroblasts from sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging 2015; 36: 2893&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">26344876</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Hall B, Castelli LM, Francis L, Woof R, Siskos AP, et al.Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis. Brain 2019; 142: 586&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6391613</ArticleId><ArticleId IdType="pubmed">30698736</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S, Heath PR, Kirby J, Wharton SB, Cookson MR, Menzies FM, et al.Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways. J Biol Chem 2003; 278: 6371&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">12475980</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SP, Rajan S, Duffy L, Mortiboys H, Higginbottom A, Grierson AJ, et al.Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis. Neurobiol Aging 2014; 35: 1499&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">24439480</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonini A, Caioli S, Saba L, Vindigni G, Biocca S, Canu N, et al.Membrane cholesterol depletion in cortical neurons highlights altered NMDA receptor functionality in a mouse model of amyotrophic lateral sclerosis. Biochim Biophys 2018; 1864: 509&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">29154925</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragno M, Mastrocola R. Dietary sugars and endogenous formation of advanced glycation endproducts: emerging mechanisms of disease. Nutrients 2017; 9: 385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409724</ArticleId><ArticleId IdType="pubmed">28420091</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker DJ, Blackburn DJ, Keatinge M, Sokhi D, Viskaitis P, Heath PR, et al.Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. Front Cell Neurosci 2015; 9: 410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4606544</ArticleId><ArticleId IdType="pubmed">26528138</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 2010; 48: 629&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolome F, Wu HC, Burchell VS, Preza E, Wray S, Mahoney CJ, et al.Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron 2013; 78: 57&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3843114</ArticleId><ArticleId IdType="pubmed">23498975</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V; ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 330: 585&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Corcia P, Moreau C, Veau S, Fournier C, Vourc&#x2019;h P, et al.1 H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS One 2010; 5: e13223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2951909</ArticleId><ArticleId IdType="pubmed">20949041</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Nadal-Desbarats L, Pradat PF, Gordon PH, Antar C, Veyrat-Durebex C, et al.Untargeted 1 H-NMR metabolomics in CSF: toward a diagnostic biomarker for motor neuron disease. Neurology 2014; 82: 1167&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">24587475</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Veyrat-Durebex C, Bocca C, Patin F, Vourc&#x2019;h P, Kouassi Nzoughet J, et al.Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS. Sci Rep 2017; 7: 17652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5732162</ArticleId><ArticleId IdType="pubmed">29247199</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccuto L, Chen CF, Pittman AR, Skinner CD, McCartney HJ, Jones K, et al.Decreased tryptophan metabolism in patients with autism spectrum disorders. Mol Autism 2013; 4: 16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3680090</ArticleId><ArticleId IdType="pubmed">23731516</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochner BR, Siri M, Huang RH, Noble S, Lei XH, Clemons PA, et al.Assay of the multiple energy-producing pathways of mammalian cells. PLoS One 2011; 6: e18147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3063803</ArticleId><ArticleId IdType="pubmed">21455318</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollong MJ, Lee G, Coukos JS, Yun H, Zambaldo C, Chang JW, et al.A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature 2018; 562: 600&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6444936</ArticleId><ArticleId IdType="pubmed">30323285</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten JC, et al.DJ-1(PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci 2003a; 24: 159&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">14598065</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al.Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003b; 299: 256&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12446870</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottger S, Melzig MF. The influence of saponins on cell membrane cholesterol. Bioorg Med Chem 2013; 21: 7118&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">24084294</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, et al.Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003; 302: 113&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">14526083</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Walsh MJ, Higginbottom A, Robin Highley J, Dickman MJ, Edbauer D, et al.Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain 2014; 137: 2040&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4065024</ArticleId><ArticleId IdType="pubmed">24866055</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Mattson MP. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol 2002; 52: 448&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">12325074</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al.Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9 p-linked FTD and ALS. Neuron 2011; 72: 245&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos KJ, Hafezparast M. Neurobiology of axonal transport defects in motor neuron diseases: opportunities for translational research? Neurobiol Dis 2017; 105: 283&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536153</ArticleId><ArticleId IdType="pubmed">28235672</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neuro-degener Dis 2005; 2: 202&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16909026</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, Treleaven CM, Fidler JA, Tamsett TJ, Bao C, Searles M, et al.Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc Natl Acad Sci U S A 2013; 110: 10812&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3696768</ArticleId><ArticleId IdType="pubmed">23754387</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolgacheva LP, Berezhnov AV, Fedotova EI, Zinchenko VP, Abramov AY. Role of DJ-1 in the mechanism of pathogenesis of Parkinson&#x2019;s disease. J Bioenerg Biomembr 2019; 51: 175&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531411</ArticleId><ArticleId IdType="pubmed">31054074</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, Bittar R, et al.Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008; 70: 1004&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18199832</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 2004; 101: 11159&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 2011; 10: 75&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergani A, Oudart H, Gonzalez De Aguilar JL, Fricker B, Rene F, Hocquette JF, et al.Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res 2007; 48: 1571&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1974855</ArticleId><ArticleId IdType="pubmed">17438338</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Higginbottom A, Heath PR, Barber S, Greenald D, Kirby J, et al.Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 2011a; 134: 2627&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170534</ArticleId><ArticleId IdType="pubmed">21908873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 2011b; 7: 616&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Meyer K, Sherwood TW, Vick J, Likhite S, Frakes A, et al.Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc Natl Acad Sci U S A 2016; 113: E6496&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5081600</ArticleId><ArticleId IdType="pubmed">27688759</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Rothstein JD. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat Rev Neurosci 2016; 17: 383&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376590</ArticleId><ArticleId IdType="pubmed">27150398</ArticleId></ArticleIdList></Reference><Reference><Citation>Halestrap AP. The mitochondrial pyruvate carrier: has it been unearthed at last? Cell Metab 2012a; 16: 141&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">22883228</ArticleId></ArticleIdList></Reference><Reference><Citation>Halestrap AP. The monocarboxylate transporter family: structure and functional characterization. IUBMB Life 2012b; 64: 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22131303</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamada Y, Araki N, Koh N, Nakamura J, Horiuchi S, Hotta N. Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochem Biophys Res Commun 1996; 228: 539&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">8920948</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris H, Rubinsztein DC. Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol 2011; 8: 108&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">22187000</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautbergue GM, Castelli LM, Ferraiuolo L, Sanchez-Martinez A, Cooper-Knock J, Higginbottom A, et al.SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits. Nat Commun 2017; 8: 16063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5504286</ArticleId><ArticleId IdType="pubmed">28677678</ArticleId></ArticleIdList></Reference><Reference><Citation>Hipkiss AR. Aging risk factors and Parkinson&#x2019;s disease: contrasting roles of common dietary constituents. Neurobiol Aging 2014; 35: 1469&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">24388766</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol 2008; 9: 125&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">18216769</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob MC, Favre M, Bensa JC. Membrane cell permeabilization with saponin and multiparametric analysis by flow cytometry. Cytometry 1991; 12: 550&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1764979</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaipuria G, Ukmar-Godec T, Zweckstetter M. Challenges and approaches to understand cholesterol-binding impact on membrane protein function: an NMR view. Cell Mol Life Sci 2018; 75: 2137&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">29520423</ArticleId></ArticleIdList></Reference><Reference><Citation>Juranek JK, Daffu GK, Geddis MS, Li H, Rosario R, Kaplan BJ, et al.Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice. Front Cell Neurosci 2016; 10: 117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4860390</ArticleId><ArticleId IdType="pubmed">27242430</ArticleId></ArticleIdList></Reference><Reference><Citation>Juranek JK, Daffu GK, Wojtkiewicz J, Lacomis D, Kofler J, Schmidt AM. Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis. Front Cell Neurosci 2015; 9: 485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4686801</ArticleId><ArticleId IdType="pubmed">26733811</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurcovicova J. Glucose transport in brain-effect of inflammation. Endocr Regul 2014; 48: 35&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">24524374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalapos MP. Methylglyoxal and glucose metabolism: a historical perspective and future avenues for research. Drug Metabol Drug Interact 2008a; 23: 69&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">18533365</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalapos MP. The tandem of free radicals and methylglyoxal. Chem Biol Interact 2008b; 171: 251&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">18164697</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufhold M, Schulz K, Breljak D, Gupta S, Henjakovic M, Krick W, et al.Differential interaction of dicarboxylates with human sodium-dicarboxylate cotransporter 3 and organic anion transporters 1 and 3. Am J Physiol Renal Physiol 2011; 301: F1026&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">21865262</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann E, Boehm BO, Sussmuth SD, Kientsch-Engel R, Sperfeld A, Ludolph AC, et al.The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurosci Lett 2004; 371: 226&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15519762</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MJ, Vargas MR, Harlan BA, Killoy KM, Ball LE, Comte-Walters S, et al.Nitration and glycation turn mature NGF into a toxic factor for motor neurons: a role for p75(NTR) and RAGE signaling in ALS. Antioxid Redox Signal 2018; 28: 1587&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5962334</ArticleId><ArticleId IdType="pubmed">28537420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk K, Gennings C, Hupf JC, Tadesse S, D&#x2019;Aurelio M, Kawamata H, et al.Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients. Ann Neurol 2014; 76: 620&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4192005</ArticleId><ArticleId IdType="pubmed">25090982</ArticleId></ArticleIdList></Reference><Reference><Citation>Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, et al.Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Molecular Neurodegener 2017; 12: 76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5655870</ArticleId><ArticleId IdType="pubmed">29065921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Bala L, Kalita J, Misra UK, Singh RL, Khetrapal CL, et al.Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis. Clin Chim 2010; 411: 563&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20096678</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JY, Song J, Kwon K, Jang S, Kim C, Baek K, et al.Human DJ-1 and its homologs are novel glyoxalases. Hum Mol Genet 2012a; 21: 3215&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">22523093</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, et al.Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 2012b; 487: 443&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Liu D, Sun L, Lu Y, Zhang Z. Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective. J Neurol Sci 2012; 317: 1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">22410257</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CL, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L, et al.Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">9539131</ArticleId></ArticleIdList></Reference><Reference><Citation>Livesey G, Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am J Clin Nutr 2008; 88: 1419&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">18996880</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Lu Y, Gendron TF, Karydas A, Tran H, Yang D, et al.Poly(GR) in C9ORF72-Related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron 2016; 92: 383&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald R, Barnes K, Hastings C, Mortiboys H. Mitochondrial abnormalities in Parkinson&#x2019;s disease and Alzheimer&#x2019;s disease: can mitochondria be targeted therapeutically? Biochem Soc Trans 2018; 46: 891&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">30026371</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E, Lorenzini I, Barrameda D, O&#x2019;Conner AG, Barrows JM, Starr A, et al.Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. Elife 2019; 8: e454114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6557627</ArticleId><ArticleId IdType="pubmed">31180318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrocola R, Nigro D, Cento AS, Chiazza F, Collino M, Aragno M. High-fructose intake as risk factor for neurodegeneration: key role for carboxy methyllysine accumulation in mice hippocampal neurons. Neurobiol Dis 2016; 89: 65&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">26851500</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K, Ferraiuolo L, Miranda CJ, Likhite S, McElroy S, Renusch S, et al.Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci U S Am 2014; 111: 829&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller A, Adeli K. Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol 2008; 24: 204&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18301272</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004; 15: 1101&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC363084</ArticleId><ArticleId IdType="pubmed">14699058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mock K, Lateef S, Benedito VA, Tou JC. High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation. J Nutr Biochem 2017; 39: 32&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27768909</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Arzberger T, Grasser FA, Gijselinck I, May S, Rentzsch K, et al.Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol 2013a; 126: 881&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, et al.The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 2013b; 339: 1335&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortiboys H, Macdonald R, Payne T, Sassani M, Jenkins T, Bandmann O. Translational approaches to restoring mitochondrial function in Parkinson&#x2019;s disease. FEBS Lett 2018; 592: 776&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">29178330</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E, Colombrita C, Gumina V, Borghi MO, Dusi S, Doretti A, et al.Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol Commun 2016; 4: 47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L, Schlagowski A, Ngo ST, Vernay A, Dirrig-Grosch S, Henriques A, et al.A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol Med 2015; 7: 526&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 1994; 91: 10625&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC45074</ArticleId><ArticleId IdType="pubmed">7938003</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Bento-Abreu A, Nonneman A, Haeck W, Staats K, Geelen V, et al.Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain 2013; 136: 471&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3572934</ArticleId><ArticleId IdType="pubmed">23378219</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat PF, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, et al.Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010; 11: 166&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">20184518</ArticleId></ArticleIdList></Reference><Reference><Citation>Raben N, Baum R, Schreiner C, Takikita S, Mizushima N, Ralston E, et al.When more is less: excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease. Autophagy 2009; 5: 111&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3257549</ArticleId><ArticleId IdType="pubmed">19001870</ArticleId></ArticleIdList></Reference><Reference><Citation>Raben N, Plotz P, Byrne BJ. Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr Mol Med 2002; 2: 145&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">11949932</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman R, Allen SP, Goodall EF, Kramer S, Ponger LL, Heath PR, et al.Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathol Appl Neurobiol 2015; 41: 201&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4329387</ArticleId><ArticleId IdType="pubmed">24750211</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozen S, Cudkowicz ME, Bogdanov M, Matson WR, Kristal BS, Beecher C, et al.Metabolomic analysis and signatures in motor neuron disease. Metabolomics 2005; 1: 101&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2553219</ArticleId><ArticleId IdType="pubmed">18820733</ArticleId></ArticleIdList></Reference><Reference><Citation>Seneff S, Wainwright G, Mascitelli L. Nutrition and Alzheimer&#x2019;s disease: the detrimental role of a high carbohydrate diet. Eur J Intern Med 2011; 22: 134&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">21402242</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N, Rao SP, Kalivendi SV. The deglycase activity of DJ-1 mitigates alpha-synuclein glycation and aggregation in dopaminergic cells: role of oxidative stress mediated downregulation of DJ-1 in Parkinson&#x2019;s disease. Free Radic Biol Med 2019; 135: 28&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">30796974</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirangelo I, Vella FM, Irace G, Manco G, Iannuzzi C. Glycation in demetalated superoxide dismutase 1 prevents amyloid aggregation and produces cytotoxic ages adducts. Front Mol Biosci 2016; 3: 55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5026054</ArticleId><ArticleId IdType="pubmed">27695694</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett 2017; S0304-3940: 30544-X.</Citation><ArticleIdList><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J, Zellweger H, Afifi AK. Muscular form of glycogenosis, type II (Pompe). Neurology 1967; 17: 537&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">5229488</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera TW, Borges K. Metabolic dysfunctions in amyotrophic lateral sclerosis pathogenesis and potential metabolic treatments. Front Neurosci 2016; 10: 611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5222822</ArticleId><ArticleId IdType="pubmed">28119559</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornalley PJ. Modification of the glyoxalase system in disease processes and prospects for therapeutic strategies. Biochem Soc Trans 1993a; 21: 531&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">8359526</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornalley PJ. The glyoxalase system in health and disease. Mol Aspects Med 1993b; 14: 287&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">8277832</ArticleId></ArticleIdList></Reference><Reference><Citation>Toyoda Y, Erkut C, Pan-Montojo F, Boland S, Stewart MP, Muller DJ, et al.Products of the Parkinson&#x2019;s disease-related glyoxalase DJ-1, D-lactate and glycolate, support mitochondrial membrane potential and neuronal survival. Biol Open 2014; 3: 777&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4133730</ArticleId><ArticleId IdType="pubmed">25063200</ArticleId></ArticleIdList></Reference><Reference><Citation>Valbuena GN, Rizzardini M, Cimini S, Siskos AP, Bendotti C, Cantoni L, et al.Metabolomic analysis reveals increased aerobic glycolysis and amino acid deficit in a cellular model of amyotrophic lateral sclerosis. Mol Neurobiol 2016; 53: 2222&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4823370</ArticleId><ArticleId IdType="pubmed">25963727</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Ploeg AT, Reuser AJ. Pompe&#x2019;s disease. Lancet 2008; 372: 1342&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">18929906</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, De Bock K, Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol 2018; 135: 489&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C, Herranz-Martin S, Karyka E, Liao C, Lewis K, Elsayed W, et al.C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat Neurosci 2017; 20: 1225&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5578434</ArticleId><ArticleId IdType="pubmed">28714954</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Grierson AJ, De Vos KJ. C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy. Small GTPases 2018; 9: 399&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5997165</ArticleId><ArticleId IdType="pubmed">27768524</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing G, Edaravone ALSSG. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2017; 16: 505&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, et al.Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 2008; 11: 251&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeagle PL, Young J, Rice D. Effects of cholesterol on (Na+,K+)-ATPase ATP hydrolyzing activity in bovine kidney. Biochemistry 1988; 27: 6449&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">2851324</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Li Q, Wu Y, Wang D, Xu L, Zhang Y, et al.Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer. Cell Commun Signal: CCS 2019; 17: 15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6383291</ArticleId><ArticleId IdType="pubmed">30786890</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>